Download Free Sample Report

Remicade Biosimilar Market, Global Outlook and Forecast 2023-2035

Remicade Biosimilar Market, Global Outlook and Forecast 2023-2035

  • Published on : 18 August 2023
  • Pages :116
  • Report Code:SMR-7780358

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.
This report aims to provide a comprehensive presentation of the global market for Remicade Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Remicade Biosimilar. This report contains market size and forecasts of Remicade Biosimilar in global, including the following market information:
Global Remicade Biosimilar Market Revenue, 2018-2023, 20242035, ($ millions)
Global Remicade Biosimilar Market Sales, 2018-2023, 20242035, (L)
Global top five Remicade Biosimilar companies in 2022 (%)
The global Remicade Biosimilar market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
100mg/10ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Remicade Biosimilar include Synthon Pharmaceuticals, LG Life Sciences, Novartis (Sandoz), Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec Inc. and Genentech (Roche Group), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Remicade Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Remicade Biosimilar Market, by Type, 2018-2023, 20242035 ($ Millions) & (L)
Global Remicade Biosimilar Market Segment Percentages, by Type, 2022 (%)
100mg/10ml
500mg/50ml
Global Remicade Biosimilar Market, by Application, 2018-2023, 20242035 ($ Millions) & (L)
Global Remicade Biosimilar Market Segment Percentages, by Application, 2022 (%)
Blood Disorders
Oncology Diseases
Global Remicade Biosimilar Market, By Region and Country, 2018-2023, 20242035 ($ Millions) & (L)
Global Remicade Biosimilar Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Remicade Biosimilar revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Remicade Biosimilar revenues share in global market, 2022 (%)
Key companies Remicade Biosimilar sales in global market, 2018-2023 (Estimated), (L)
Key companies Remicade Biosimilar sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Fosun Pharmaceutical
Livzon Pharmaceutical
Anke Biotechnology
Hualan Biological Engineering
Walvax Biotechnology
Hisun Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Remicade Biosimilar, market overview.
Chapter 2: Global Remicade Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Remicade Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Remicade Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Remicade Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.